We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (116)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1281 result(s) found, displaying 1126 to 1150
-
Safety alertsTesting on Australian Poly Implant Prothèse (PIP) samples of implants has been undertaken by TGA
-
Safety alertsConsumers are advised to stop using Hydroxycut products due to serious adverse reactions, including liver toxicity. We highlight differences between US and Australian formulations and recommend caution. Consult your doctor if concerned.
-
Safety alertsGardasil is a vaccine that protects young women from the strains of human papillomavirus (HPV) that cause 70% of cervical cancers.
-
Market actions
-
Safety alertsStop using Viagra (sildenafil) 100mg tablets due to counterfeit concerns. Return them to your pharmacy and consult your doctor if you have any concerns.
-
Safety alertsContinuing investigation into issues with Poly Implant Prothèse (PIP) silicone gel-filled breast implants
-
Safety alertsRotavirus vaccines Rotarix and RotaTeq still recommended despite pig virus DNA fragments found.
-
Safety alertsWe are investigating adverse reactions to the 2010 flu vaccine in young children in Western Australia and have paused its use for kids under 5.
-
Market actionsMedical Visions Australia Pty Ltd following consultation with the Therapeutic Goods Administration is undertaking the recall of all non implanted silicone gel breast implants manufactured by Poly Implant Prothèse (PIP). The recall applies to all models of this type of implant.
-
Market actionsBatch AR169 may contain AMLO 5 tablets (5mg amlodipine).
-
-
Safety alertsConsumers are advised to stop using Hydroxycut products due to reports of serious adverse reactions, including liver toxicity, and to consult their doctor if they have any concerns.
-
Safety alertsBe aware that Hydroxycut products purchased via the internet may be sourced from the US and may contain ingredients which are not permitted in low-risk medicines in Australia
-
Safety alertsWeight loss drug Sibutramine (Reductil) under safety review for cardiovascular risks.
-
Safety alertsWe are advising that there are supply issues with Physeptone (methadone) tablets due to quality control problems.
-
Safety alertsApproval has been granted for the Panvax H1N1 vaccine in children starting at 6 months, with Panvax H1N1 Junior for ages 6 months to 3 years.
-
Safety alertsIn October 2009 an anaphylactic reaction to the Panvax H1N1 pandemic influenza vaccine was reported in Western Australia in a person known to have a pre-existing latex allergy.
-
Safety alerts
-
-
Safety alertsGinkgo biloba products with high quercetin and rutin levels have been identified. Quality standards are being reviewed.
-
Safety alertsPanvax H1N1 influenza vaccine has been approved for use in adults and children over 10 years old, with additional data needed for younger children.
-
Market actions
-
Safety alertsAdvise to exercise caution when using Australian Hydroxycut products
-
Market actionsChuan Xiong Cha Tiao Wan pills have been recalled due to the presence of aristolochic acids, which can cause severe kidney damage and urinary tract cancer. Stop using them immediately and consult your doctor for advice.
-
Market actions